Comparative study of poly (lactic-co-glycolic acid)-poly ethyleneimine-plasmid DNA microparticles prepared using double emulsion methods

被引:60
作者
Zhang, Xue-Qing [1 ]
Intra, Janjira [1 ]
Salem, Aliasger K. [1 ]
机构
[1] Univ Iowa, Coll Pharm, Div Pharmaceut, Iowa City, IA 52242 USA
关键词
PLGA; PEI; microparticle; non-viral gene delivery; formulation;
D O I
10.1080/02652040701659347
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Controlled release of plasmid DNA (pDNA) from biodegradable poly lactic-co-glycolic acid (PLGA) microparticles has the potential to enhance transgene expression. However, barriers to this approach include limited encapsulation efficiency, pDNA damage during fabrication and confinement of the microparticles inside phagolysosomal compartments. Combining PLGA with poly ethyleneimine (PEI) can improve protection of pDNA during fabrication, increase encapsulation efficiencies and impart the PLGA microparticles with the capacity to escape the phagolysosomal compartments. This study compares three promising formulation methods for preparing PLGA PEI pDNA microparticles and evaluates for buffering capacity, cellular uptake, transfection efficiency and toxicity. In the first method, PLGA PEI pDNA microparticles are prepared by entrapping pDNA in blended PLGA/PEI using the double emulsion water-in-oil-in-water solvent evaporation technique (PA). In a second approach, PEI-pDNA polyplexes are prepared and then entrapped in PLGA microparticles using a double emulsion solvent evaporation method (PB). Microparticles prepared using formulation methods PA and PB are then compared against PLGA microparticles with PEI conjugated to the surface using carbodiimide chemistry (PC); 0.5% PVA is identified as the optimum concentration of surfactant for generating the strongest transfection efficiencies. N:P ratios of 5 and 10 are selected for preparation of each group. Gel electrophoresis demonstrates that all PLGA microparticle formulations have strong pDNA binding capacity. An MTT assay shows that in vitro cytotoxicity of PLGA PEI microparticles is significantly lower than PEI alone. PLGA PEI pDNA microparticles mediate higher cellular uptake efficiency and consequently higher transgene expression than unmodified PLGA microparticles in COS7 and HEK293 cells. Preparing PEI-pDNA polyplexes prior to entrapment in PLGA microparticles (PB) results in the highest pDNA loading. This is 2.5-fold higher than pDNA loading in unmodified PLGA microparticles. PLGA PEI pDNA microparticles prepared using method PB generates the strongest transfection efficiencies, which are 500-fold higher than unmodified PLGA pDNA microparticles in HEK293 cells and 1800-fold higher in COS-7 cells. The highest transfection efficiencies generated from microparticles prepared using method PB is achieved using an N:P ratio of 5.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 46 条
[1]   Formulating poly(lactide-co-glycolide) particles for plasmid DNA delivery [J].
Abbas, Aiman O. ;
Donovan, Maureen D. ;
Salem, Aliasger K. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (07) :2448-2461
[2]   PLGA microspheres containing plasmid DNA: Preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization [J].
Ando, S ;
Putnam, D ;
Pack, DW ;
Langer, R .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 88 (01) :126-130
[3]   PLGA-PEI nanoparticles for gene delivery to pulmonary epithelium [J].
Bivas-Benita, M ;
Romeijn, S ;
Junginger, HE ;
Borchard, G .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 58 (01) :1-6
[4]   A VERSATILE VECTOR FOR GENE AND OLIGONUCLEOTIDE TRANSFER INTO CELLS IN CULTURE AND IN-VIVO - POLYETHYLENIMINE [J].
BOUSSIF, O ;
LEZOUALCH, F ;
ZANTA, MA ;
MERGNY, MD ;
SCHERMAN, D ;
DEMENEIX, B ;
BEHR, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (16) :7297-7301
[5]   Influence of formulation parameters on the characteristics of poly(D,L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA [J].
Capan, Y ;
Woo, BH ;
Gebrekidan, S ;
Ahmed, S ;
DeLuca, PP .
JOURNAL OF CONTROLLED RELEASE, 1999, 60 (2-3) :279-286
[6]   Preparation and characterization of poly (D,L-lactide-co-glycolide) microspheres for controlled release of poly(L-lysine) complexed plasmid DNA [J].
Capan, Y ;
Woo, BH ;
Gebrekidan, S ;
Ahmed, S ;
DeLuca, PP .
PHARMACEUTICAL RESEARCH, 1999, 16 (04) :509-513
[7]   Stability of poly(L-lysine)-complexed plasmid DNA during mechanical stress and DNase I treatment [J].
Capan, Y ;
Woo, BH ;
Gebrekidan, S ;
Ahmed, S ;
DeLuca, PP .
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 1999, 4 (04) :491-498
[8]   A new delivery system for antisense therapy: PLGA microspheres encapsulating oligonucleotide/polyethyleneimine solid complexes [J].
De Rosa, G ;
Bochot, A ;
Quaglia, F ;
Besnard, M ;
Fattal, E .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 254 (01) :89-93
[9]   Cationic polymer based gene delivery systems [J].
De Smedt, SC ;
Demeester, J ;
Hennink, WE .
PHARMACEUTICAL RESEARCH, 2000, 17 (02) :113-126
[10]   BIODEGRADABLE AND BIOCOMPATIBLE POLY(DL-LACTIDE-CO-GLYCOLIDE) MICROSPHERES AS AN ADJUVANT FOR STAPHYLOCOCCAL ENTEROTOXIN-B TOXOID WHICH ENHANCES THE LEVEL OF TOXIN-NEUTRALIZING ANTIBODIES [J].
ELDRIDGE, JH ;
STAAS, JK ;
MEULBROEK, JA ;
TICE, TR ;
GILLEY, RM .
INFECTION AND IMMUNITY, 1991, 59 (09) :2978-2986